Ace Urea Nitrogen Reagent, Calcium-Arseazo Reagent, Creatinine Reagent, Inorganic Phosphorus U.V. Reagent,Urine Standard
Urease, Photometric, Urea Nitrogen. 510(k) K103615, from Alfa Wassermann Diagnostic Technologies, Inc. (West Caldwell, NJ). Product code CDN, class 2.
As of Nov 21, 2026, K103615 is an FDA 510(k) held by Alfa Wassermann Diagnostic Technologies, Inc., substantially equivalent on Sep 8, 2011 after 273 days, with 1 recall tied to it in FDA's recall database.
- Review time: 273 days
- Recalls: 1
The ACE Calcium-Arsenazo Reagent is intended for the quantitative determination of calcium in urine using the ACE and ACE Alera Clinical Chemistry Systems. Calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany. This test is intended for use in clinical laboratories or physician office laboratories.
- Roche Reagent for BunK954000 · Roche Diagnostic Systems, Inc. · Oct 25, 1995
- Cobas Ready Calcium ReagentK896224 · Roche Diagnostic Systems, Inc. · Aug 17, 1990
- Roche Reagent for Inorganic PhosphorusK883962 · Roche Diagnostic Systems, Inc. · Nov 29, 1988
- Chem 1 Clinical Analyzer (Method Urine Creatinine)K901229 · Technicon Instruments Corp. · May 4, 1990
- Multi-Chemistry Linearity StandardK875285 · Verichem Laboratories, Inc. · Sep 2, 1988
| Started | Recall | Status |
|---|---|---|
| Oct 10, 2012 | Z-0743-2013Inorganic phosphorus assays using System Diluent Lot 155599 may not product acceptable calibration results. | Terminated |
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 9, 2010
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1770
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files